These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16777822)

  • 1. Summary proceedings from the apnea-of-prematurity group.
    Finer NN; Higgins R; Kattwinkel J; Martin RJ
    Pediatrics; 2006 Mar; 117(3 Pt 2):S47-51. PubMed ID: 16777822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal apnea: what's new?
    Abu-Shaweesh JM; Martin RJ
    Pediatr Pulmonol; 2008 Oct; 43(10):937-44. PubMed ID: 18780339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, controlled trial of oral creatine supplementation (not effective) for apnea of prematurity.
    Bohnhorst B; Geuting T; Peter CS; Dördelmann M; Wilken B; Poets CF
    Pediatrics; 2004 Apr; 113(4):e303-7. PubMed ID: 15060257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current options in the management of apnea of prematurity.
    Bhatia J
    Clin Pediatr (Phila); 2000 Jun; 39(6):327-36. PubMed ID: 10879934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromodulation of Limb Proprioceptive Afferents Decreases Apnea of Prematurity and Accompanying Intermittent Hypoxia and Bradycardia.
    Kesavan K; Frank P; Cordero DM; Benharash P; Harper RM
    PLoS One; 2016; 11(6):e0157349. PubMed ID: 27304988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose doxapram therapy for idiopathic apnea of prematurity.
    Yamazaki T; Kajiwara M; Itahashi K; Fujimura M
    Pediatr Int; 2001 Apr; 43(2):124-7. PubMed ID: 11285061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine: an evidence-based success story in VLBW pharmacotherapy.
    Dobson NR; Hunt CE
    Pediatr Res; 2018 Sep; 84(3):333-340. PubMed ID: 29983414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based methylxanthine use in the NICU.
    Spitzer AR
    Clin Perinatol; 2012 Mar; 39(1):137-48. PubMed ID: 22341542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroesophageal reflux and apnea of prematurity: no temporal relationship.
    Peter CS; Sprodowski N; Bohnhorst B; Silny J; Poets CF
    Pediatrics; 2002 Jan; 109(1):8-11. PubMed ID: 11773535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the efficacy and safety of aminophylline in treatment of apnea of prematurity in neonatal intensive care unit.
    Ye C; Miao C; Yu L; Dong Z; Zhang J; Mao Y; Lu X; Lyu Q
    Pediatr Neonatol; 2019 Feb; 60(1):43-49. PubMed ID: 29673564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
    Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
    Lista G; Fabbri L; Polackova R; Kiechl-Kohlendorfer U; Papagaroufalis K; Saenz P; Ferrari F; Lasagna G; Carnielli VP;
    Neonatology; 2016; 109(3):221-7. PubMed ID: 26820884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate].
    Ducrocq S; Biran-Mucignat V; Boelle PY; Lebas F; Baudon JJ; Gold F
    Arch Pediatr; 2006 Oct; 13(10):1299-304. PubMed ID: 16919922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Xanthines in apnea of premature infants. Influence on gastroesophageal reflux].
    Sacré L; Vandenplas Y
    Arch Fr Pediatr; 1987 May; 44(5):383-5. PubMed ID: 3619572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxapram Treatment for Apnea of Prematurity: A Systematic Review.
    Vliegenthart RJ; Ten Hove CH; Onland W; van Kaam AH
    Neonatology; 2017; 111(2):162-171. PubMed ID: 27760427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine for apnea of prematurity: a neonatal success story.
    Kreutzer K; Bassler D
    Neonatology; 2014; 105(4):332-6. PubMed ID: 24931325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The xanthine treatment of apnea of prematurity.
    Lucey JF
    Pediatrics; 1975 May; 55(5):584-6. PubMed ID: 1128983
    [No Abstract]   [Full Text] [Related]  

  • 18. Sodium Alginate (Gaviscon®) does not reduce apnoeas related to gastro-oesophageal reflux in preterm infants.
    Corvaglia L; Spizzichino M; Zama D; Aceti A; Mariani E; Legnani E; Faldella G
    Early Hum Dev; 2011 Dec; 87(12):775-8. PubMed ID: 21696897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Apnea of prematurity - characteristic and treatment].
    Goryniak A; Szczęśniak A; Śleboda D; Dołęgowska B
    Postepy Biochem; 2017; 63(2):151-154. PubMed ID: 28689383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial.
    Schmidt B
    Biol Neonate; 2005; 88(3):208-13. PubMed ID: 16210843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.